BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24441646)

  • 21. Systematic Identification of Pharmacological Targets from Small-Molecule Phenotypic Screens.
    Liu X; Baarsma HA; Thiam CH; Montrone C; Brauner B; Fobo G; Heier JS; Duscha S; Königshoff M; Angeli V; Ruepp A; Campillos M
    Cell Chem Biol; 2016 Oct; 23(10):1302-1313. PubMed ID: 27667560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative Prioritization of Tool Compounds for Phenotypic Screening.
    Wang Y; Jenkins JL
    Methods Mol Biol; 2018; 1787():195-206. PubMed ID: 29736720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Target Identification of Compounds from a Cell Viability Phenotypic Screen Using a Bead/Lysate-Based Affinity Capture Platform.
    Tang H; Duggan S; Richardson PL; Marin V; Warder SE; McLoughlin SM
    J Biomol Screen; 2016 Feb; 21(2):201-11. PubMed ID: 26676096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple statistical test to infer the causality of target/phenotype correlation from small molecule phenotypic screens.
    Wei X; Hoffman AF; Hamilton SM; Xiang Q; He Y; So WV; So SS; Mark D
    Bioinformatics; 2012 Feb; 28(3):301-5. PubMed ID: 22155864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Historical Bioactivity Data in the Deconvolution of Phenotypic Screens.
    Bornot A; Blackett C; Engkvist O; Murray C; Bendtsen C
    J Biomol Screen; 2014 Jun; 19(5):696-706. PubMed ID: 24441646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Phenotypic Hit to Chemical Probe: Chemical Biology Approaches to Elucidate Small Molecule Action in Complex Biological Systems.
    Pasquer QTL; Tsakoumagkos IA; Hoogendoorn S
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolution of library design: crafting smart compound collections for phenotypic screens.
    Spear KL; Brown SP
    Drug Discov Today Technol; 2017 Mar; 23():61-67. PubMed ID: 28647087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery.
    Jung HJ; Kwon HJ
    Arch Pharm Res; 2015 Sep; 38(9):1627-41. PubMed ID: 26040984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell perturbation screens for target identification by RNAi.
    Demir K; Boutros M
    Methods Mol Biol; 2012; 910():1-13. PubMed ID: 22821589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical genetics-based target identification in drug discovery.
    Cong F; Cheung AK; Huang SM
    Annu Rev Pharmacol Toxicol; 2012; 52():57-78. PubMed ID: 21819237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target deconvolution techniques in modern phenotypic profiling.
    Lee J; Bogyo M
    Curr Opin Chem Biol; 2013 Feb; 17(1):118-26. PubMed ID: 23337810
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.